Evidence map›Paper›PMID 36087524›Full record

ArticleEBioMedicine2022

Real-time metagenomics-based diagnosis of community-acquired meningitis: A prospective series, southern France.

Madjid Morsli, Agathe Boudet, Quentin Kerharo, Robin Stephan, Florian Salipante, Catherine Dunyach-Remy, Linda Houhamdi, Pierre-Edouard Fournier, Jean Philippe Lavigne, Michel Drancourt

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in EBioMedicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07391995 (Evaluation of a New Diagnostic Tool), which is not on this map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07391995 recruitingnot on this mapstarted 2026, after this paper: background citation

Evaluation of a New Diagnostic Tool (MinION) for Identifying Microorganisms in the Foot Wounds of Patients Living With Diabetic Foot Osteomyelitis (DFOM)

TypeobservationalSponsorCentre Hospitalier Universitaire de NīmesRan2026 to 2026Enrolled43ConditionsDiabetes Mellitus, Diabetes Complications, Diabetic Peripheral Neuropathy
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. [Advances in the diagnosis and treatment of patients with multidrug-resistant bacterial infections combined with severe liver disease].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Progression of antibiotic resistance inClinical microbiology reviews · 2025
    Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Defining a metagenomic threshold for detecting low abundances ofFrontiers in cellular and infection microbiology · 2024
    Article
  16. Whole Genome Sequencing: Applications in Clinical Bacteriology.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2024
    Review
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Madjid MorsliIHU Méditerranée Infection, Marseille, France; IRD, MEPHI, IHU Méditerranée Infection, Aix-Marseille-Université, France.
Agathe BoudetVBIC, INSERM U 1047, Université de Montpellier, France; Service de Microbiologie et Hygiène Hospitalière, CHU Nîmes, Nîmes, France.
Quentin KerharoIHU Méditerranée Infection, Marseille, France; Laboratoire de Microbiologie, Assistance Publique-Hôpitaux de Marseille, IHU, Méditerranée Infection, Marseille, France.
Robin StephanService de Microbiologie et Hygiène Hospitalière, CHU Nîmes, Nîmes, France.
Florian SalipanteService de Microbiologie et Hygiène Hospitalière, CHU Nîmes, Nîmes, France; Service de Biostatistique, Epidémiologie, Santé Publique, Innovation en Méthodologie, CHU Nîmes, Nîmes, France.
Catherine Dunyach-RemyVBIC, INSERM U 1047, Université de Montpellier, France; Service de Microbiologie et Hygiène Hospitalière, CHU Nîmes, Nîmes, France.
Linda HouhamdiIHU Méditerranée Infection, Marseille, France.
Pierre-Edouard FournierIHU Méditerranée Infection, Marseille, France; VITROME, IHU Méditerranée Infection, Aix-Marseille Université, Marseille, France.
Jean Philippe LavigneVBIC, INSERM U 1047, Université de Montpellier, France; Service de Microbiologie et Hygiène Hospitalière, CHU Nîmes, Nîmes, France.
Michel DrancourtIHU Méditerranée Infection, Marseille, France; IRD, MEPHI, IHU Méditerranée Infection, Aix-Marseille-Université, France; Laboratoire de Microbiologie, Assistance Publique-Hôpitaux de Marseille, IHU, Méditerranée Infection, Marseille, France. Electronic address: michel.drancourt@univ-amu.fr.
Méditerranée Infection Foundation · FRInserm · FRCentre Hospitalier Universitaire de Nîmes · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPoint-Of-Care (POC) diagnosis of life-threatening community-acquired meningitis currently relies on multiplexed RT-PCR assays, that lack genotyping and antibiotic susceptibility profiling. We assessed the usefulness of real-time metagenomics (RTM) directly applied to the cerebrospinal fluid (CSF) for the identification, typing and susceptibility profiling of pathogens responsible for community-acquired meningitis.

methodsA series of 52 CSF samples from patients suspected of having community-acquired meningitis, were investigated at POC by direct RTM in parallel to routine real-time multiplex PCR (RT-PCR) and bacterial culture, for the detection of pathogens. RTM-generated sequences were blasted in real-time against an in-house database incorporating the panel of 12 most prevalent pathogens and against NCBI using EPI2ME online software, for pathogen identification. In-silico antibiogram and genotype prediction were determined using the ResFinder bio-tool and MLST online software.

findingsOver eight months, routine multiplex RT-PCR yielded 49/52 positive CSFs, including 21 Streptococcus pneumoniae, nine Neisseria meningitidis, eight Haemophilus influenzae, three Streptococcus agalactiae, three Herpesvirus-1, two Listeria monocytogenes, and one each of Escherichia coli, Staphylococcus aureus and Varicella-Zoster Virus. Parallel RTM agreed with the results of 47/52 CSFs and revealed two discordant multiplex RT-PCR false positives, one H. influenzae and one S. pneumoniae. Both multiplex RT-PCR and RTM agreed on the negativity of three CSFs. While multiplex RT-PCR routinely took 90 min, RTM took 120 min, although the pipeline analysis detected the pathogen genome after 20 min of sequencing in 33 CSF samples; and after two hours in 14 additional CSFs; yielding > 50% genome coverage in 19 CSFs. RTM identified 14 pathogen genotypes, including a majority of H. influenzae b, N. meningitidis B and S. pneumoniae 11A and 3A. In all 16 susceptible cultured bacteria, the in-silico antibiogram agreed with the in-vitro antibiogram in 10 cases, available within 48 h in routine bacteriology.

interpretationIn addition to pathogen detection, RTM applied to CSF samples offered supplementary information on bacterial profiling and genotyping. These data provide the proof-of-concept that RTM could be implemented in a POC laboratory for one-shot diagnostic and genomic surveillance of pathogens responsible for life-threatening meningitis.

fundingThis work was supported by the French Government under the Investments in the Future programme managed by the National Agency for Research reference: Méditerranée Infection 10-IAHU-03.

Indexed as

Meningitis, BacterialNeisseria meningitidisAnti-Bacterial AgentsBacteriaEscherichia coliHaemophilus influenzaeHumansMultilocus Sequence TypingMultiplex Polymerase Chain ReactionStreptococcus pneumoniaeAnti-Bacterial AgentsAntibiotic resistanceCommunity-acquired meningitisGenotypingPoint-of-care (POC) laboratory diagnosisReal-time metagenomics

Identifiers

PMID36087524
PMCPMC9463524
OpenAlexW4294896585

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.